ARCHIVES

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

President Accepts Rauscher Resignation

October 1, 1976

Phase III Trial Would Give Clearer Picture of C225 Role

March 8, 2002

Oncology Nursing Foundation Offers Research Fellowship, Clinical Scholar Award

September 29, 1995

FDA Committee to Discuss Policy On Combinations

January 7, 1977

Reports Propose Stricter Rules To Protect Research Participants

October 11, 2002

Cooperative Groups Get Reprieve From Cut As Budget Is Flatlined At Fiscal 2006 Level.

June 8, 2007